The clinical investigator

, Volume 70, Issue 3–4, pp 352–367 | Cite as

Uptake of tobacco smoke constituents on exposure to environmental tobacco smoke (ETS)

  • G. Scherer
  • C. Conze
  • A. R. Tricker
  • F. Adlkofer
Original Article


For the purpose of risk evaluation, passive smoking is frequently regarded as low-dose cigarette smoking. However, since the physical, chemical and biological properties of mainstream smoke (MS), which is inhaled by the smoker and environmental tobacco smoke (ETS), which is breathed by the passive smoker are quite different, risk extrapolation from active smoking to passive smoking is of doubtful value. In a series of experimental exposure studies we compared the uptake of tobacco smoke constituents by active and passive smoking. The results show that biomarkers which were found to be elevated after experimental ETS exposure, such as nicotine and cotinine in plasma and urine as well as thioethers in urine, indicate gas-phase exposure in passive smokers, but particle-phase exposure in active smokers. Biomarkers which should indicate the uptake of particle-bound, genotoxic substances with ETS, such as urinary mutagenicity, metabolites of polycyclic aromatic hydrocarbons (PAH) and DNA adducts, were not found to be elevated even after extremely high ETS exposure. From these results we conclude that a risk evaluation for passive smoking on the basis of dosimetric data is currently not possible.

Key words

Environmental tobacco smoke (ETS) Passive smoking Smoking Biomonitoring Gas phase Particle phase Genotoxic substances 









butanol extraction




carbon monoxide




DNA binding substances


diagonal radioactive zone


environmental tobacco smoke


gas chromatography


gas chromatography coupled to mass spectrometry


high performance liquid chromatography


3-hydroxypropylmercapturic acid


mainstream smoke






nitrogen oxides (NO/NO2)


polycyclic aromatic hydrocarbons




nuclease P1


respirable particles


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adlkofer F, Scherer G, v Maltzan C, v Mayerinck L, Jarczyk L, Martin F, Grimmer G (1990) Dietary influence on urinary excretion of OH-phenanthrenes, thioethers and mutagenicity. In: Vainio H, Sorsa M, McMichael AJ (eds) Complex mixtures and cancer risk. International Agency for Research on Cancer, Lyon, pp 415–420.Google Scholar
  2. 2.
    Adlkofer G, Scherer G, Conze C, Angerer J, Lehnert G (1990) Significance of exposure to benzene and other toxic compounds through environmental tobacco smoke. J Cancer Res Clin Oncol 116:591–598.CrossRefPubMedGoogle Scholar
  3. 3.
    Aringer L, Lidums V (1988) The influence of diet and other factors on urinary levels of thioethers. Int Arch Occup Environ Health 61:123–130.CrossRefPubMedGoogle Scholar
  4. 4.
    Bos RP, Theuws JLG, Henderson PM (1983) Excretion of mutagens in human urine after passive smoking. Cancer Lett 19:85–90.CrossRefPubMedGoogle Scholar
  5. 5.
    Buonarati MH, Turteltaub KW, Shen NH, Felton JS (1990) Role of sulfatation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind DNA. Mutat Res 245:185–190.CrossRefPubMedGoogle Scholar
  6. 6.
    Chasseaud LF (1979) The role of glutathione and glutathione-S-transferase in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res 29:175–274.CrossRefPubMedGoogle Scholar
  7. 7.
    Claxton LD, Morin RS, Hughes TJ, Lewtas J (1989) A genotoxic assessment of environmental tobacco smoke using bacterial bioassays. Mutat Res 222:81–99.CrossRefPubMedGoogle Scholar
  8. 8.
    Conner JM (1986) Development of a method for estimating the contribution of environmental tobacco smoke (ETS) to indoor respirable suspended particles. Paper presented at the 40th Tobacco Chemists' Research Conference. 13–16 October, Knoxville, Tennessee, USA.Google Scholar
  9. 9.
    Doll R (1986) Lung cancer: observed and expected changes in incidence from active and passive smoking. Abstracts of Lectures, Symposia and Free Communications of the 14th Int Cancer Congress, Budapest. Vol 1.Google Scholar
  10. 10.
    Draminski W, Eder E, Henschler D (1983) A new pathway of acrolein metabolism in rats. Arch Toxicol 52:243–247.CrossRefPubMedGoogle Scholar
  11. 11.
    Eatough DJ, Benner CL, Tang H, Landon V, Richards G, Caka FM, Crawford J, Lewis EA, Hansen LD (1989) The chemical composition of environmental tobacco smoke. III. Identification of conservative tracers of environmental tobacco smoke. Environ Int 15:19–28.CrossRefGoogle Scholar
  12. 12.
    Ehling UH, Averbeck D, Cerutti PA, Friedman J, Greim H, Kolbye AC, Mendelsohn ML (1983) Review of the evidence for the presence or absence of thresholds in the induction of genetic effects by genotoxic chemicals. Mutat Res 123:281–341.CrossRefPubMedGoogle Scholar
  13. 13.
    Einistö P, Nohmi T, Watanabe M, Ishidate M (1990) Sensitivity of Salmonella typhimurium YG 1024 to urine mutagenicity caused by cigarette smoking. Mutat Res 245:87–92.CrossRefPubMedGoogle Scholar
  14. 14.
    Eudy LW, Thorne FA, Heavner DL, Green CR, Ingebretsen BJ (1985) Studies on the vapor-particulate phase distribution of the environmental nicotine. Paper presented at the 39th Tobacco Chemists' Research Conference. October 2–5, 1985, Montreal, Canada.Google Scholar
  15. 15.
    Fleiss JL, Gross AJ (1991) Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: A critique. J Clin Epidemiol 44:127–139.CrossRefPubMedGoogle Scholar
  16. 16.
    Foiles PG, Miglietta LM, Quart AM, Quart A, Kabat GC, Hecht SS (1989) Evaluation of 32P-postlabeling analysis of DNA from exfoliated oral mucosa cells as a means of monitoring exposure of the oral cavity to genotoxic agents. Carcinogenesis 10:1429–1434.CrossRefPubMedGoogle Scholar
  17. 17.
    Grimmer G, Naujack KW, Dettbarn G (1987) Gaschromatographic determination of polycyclic aromatic hydrocarbons, aza-arenes, aromatic amines in sidestream smoke of cigarettes. Toxicol Lett 35:117–124.CrossRefPubMedGoogle Scholar
  18. 18.
    Grimmer G, Brune H, Dettbarn G, Naujack KW, Mohr U, Wenzel-Hartung R (1988) Contribution of polycyclic aromatic compounds to the carcinogenicity of sidestream smoke of cigarettes evaluated by implantation into the lungs of rats. Cancer Lett 43:173–177.CrossRefPubMedGoogle Scholar
  19. 19.
    Heinonen T, Kytbniemi V, Sorsa M, Vainio H (1983) Urinary excretion of thioethers among low-tar and medium-tar cigarette smokers. Int Arch Occup Environ Health 52:11–16.CrossRefPubMedGoogle Scholar
  20. 20.
    Hengen N, Hengen M (1978) Gas-liquid chromatographic determination of nicotine and cotinine in plasma. Clin Chem 24:50–53.PubMedGoogle Scholar
  21. 21.
    Hiller FC, McCusker KT, Mazumder MK, Wilson JD, Bone RC (1982) Deposition of sidestream cigarette smoke in human respiratory tract. Am Rev Respir Dis 125:406–408.PubMedGoogle Scholar
  22. 22.
    Hinds W, First MW, Huber GL, Shea JW (1983) A method for measuring respiratory deposition of cigarette smoke during smoking. Am Ind Hyg Assoc J 44:113–118.CrossRefPubMedGoogle Scholar
  23. 23.
    Hoepfner I, Dettbarn G, Scherer G, Grimmer G, Adlkofer F (1987) Hydroxyphenanthrenes in the urine of non-smokers and smokers. Toxicol Lett 35:67–71.CrossRefPubMedGoogle Scholar
  24. 24.
    Holz O, Krause Th, Scherer G, Schmidt-Preuß U, Rüdiger HW (1990) 32P-Postlabelling analysis of DNA adducts in monocytes of smokers and passive smokers. Int Arch Occup Environ Health 62:299–303.CrossRefPubMedGoogle Scholar
  25. 25.
    Husgafvel-Pursiainen K, Sorsa M, Engström K, Einistö P (1987) Passive smoking at work: biochemical and biological measures of exposure to environmental tobacco smoke. Int Arch Occup Environ Health 59:337–345.CrossRefPubMedGoogle Scholar
  26. 26.
    International Agency for Research on Cancer (1986) Tobacco smoking. (IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 38) IARC. Lyon.Google Scholar
  27. 27.
    Jahnke GD, Thompson GL, Walker MP, Gallagher JE, Lucier GW, DiAugustine R (1990) Multiple DNA adducts in lymphocyte of smokers and nonsmokers determined by 32P-postlabeling analysis. Carcinogenesis 11:205–211.CrossRefPubMedGoogle Scholar
  28. 28.
    Jarczyk L, Scherer G, vMaltzan C, Luu HT, Adlkofer F (1989) Comparison of intake of nicotine from environmental tobacco smoke between nose and mouth breathers. Environ Int 15:35–40.CrossRefGoogle Scholar
  29. 29.
    Jarvis MJ (1987) Uptake of environmental tobacco smoke. In: O'Neill IK, Brunnemann KD, Bodet B, Hoffmann D (eds) IARC Scientific Publication No 81. International Agency for Research on Cancer, Lyon, pp 43–58.Google Scholar
  30. 30.
    Jongeneelen FJ, Bos RP, Anzion RBM, Theuws JLG, Henderson PT (1986) Biological monitoring of polycyclic aromatic hydrocarbons. Metabolites in urine. Scand J Work Environ Health 12:137–143.CrossRefPubMedGoogle Scholar
  31. 31.
    Kado NY, Tesluk SJ, Mammond SK, Woskie SR, Samuels SJ, Schenker MB (1987) Use of a Salmonella micro preincubation procedure for studying personal exposure to mutagens in environmental tobacco smoke: pilot study of urine and airborne mutagenicity from passive smoking. In: Sand SS, DeMarini DM, Mass MJ, Moore MM, Mumford JL (eds) Short-term bioassays in the analysis of complex environmental mixtures. V. Environ Sci Res 36:375–390.Google Scholar
  32. 32.
    Kaye CM (1973) Biosynthesis of mercapturic acids from allyl alcohol, allyl esters and acrolein. Biochem J 134:1093–1101.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Klus H, Begutter H, Ball M, Intorp M (1987) Environmental tobacco smoke in real life situations. Poster presented at the 4th International Conference on Indoor Air Quality and Climate, 17–21 August, Berlin.Google Scholar
  34. 34.
    Klus H, Kuhn H (1982) Verteilung verschiedener Tabakrauchbestandteile auf Haupt- und Nebenstromrauch (Eine Übersicht). Beitr Tabakforsch Int 11:229–265.Google Scholar
  35. 35.
    Kuwata K, Uebori M, Yamasaki H, Kuge Y (1983) Determination of aliphatic aldehydes in air by liquid chromatography. Anal Chem 55:2013–2016.CrossRefGoogle Scholar
  36. 36.
    Langone J, Gjika HB, Van Vunakis H (1973) Nicotine and its metabolites: radioimmunoassay for nicotine and cotinine. Biochemistry 12:5025–5030.CrossRefPubMedGoogle Scholar
  37. 37.
    Letzel H, Überla K (1987) Meta-analyses on passive smoking and lung cancer. In: Kasuga H (ed) Indoor air quality. Springer, Berlin, pp 316–320.Google Scholar
  38. 38.
    Ling PI, Löfroth G, Lewtas J (1987) Mutagenic determination of passive smoking. Toxicol Lett 35:147–151.CrossRefPubMedGoogle Scholar
  39. 39.
    Martin F, Hoepfner I, Scherer G, Adlkofer F, Dettbarn G, Grimmer G (1989) Urinary excretion of hydroxy-phenanthrenes after intake of polycyclic aromatic hydrocarbons. Environ Int 15:41–47.CrossRefGoogle Scholar
  40. 40.
    Mohtashamipur E, Müller G, Norpoth K, Endrikat M, Stücker W (1987) Urinary excretion of mutagens in passive smokers. Toxicol Lett 35:141–146.CrossRefPubMedGoogle Scholar
  41. 41.
    Nakhosteen JA, Lindemann L, Vicira J (1982) Mucociliary clearance. Dtsch Med Wochenschr 107:1713–1716.CrossRefPubMedGoogle Scholar
  42. 42.
    US Department of Health and Humans Services (1984) NIOSH manual of analytical methods, vol 1. Method 1500/1501. US Government Printing Office, Washington DC, pp 84–100.Google Scholar
  43. 43.
    Odgen MW (1986) Improved gas chromatographic quantitation of trace levels of environmental nicotine. Paper presented at the 40th Tobacco Chemists' Research Conference, 13–16 October, Knoxville, Tennessee, USA.Google Scholar
  44. 44.
    Odgen MW, Maiolo KC (1988) Collection and analysis of solanesol as a tracer of environmental tabacco smoke (ETS). In: Perry R, Kirk PW (eds) Indoor and ambient air quality. Selper, London, pp 77–88.Google Scholar
  45. 45.
    Odgen MW, Maiolo K (1990) Comparison of GC and LC for determining solanesol in environmental tobacco smoke. Paper presented at the 44th Tobacco Chemists' Research Conference, 1–3 October, Winston-Salem, North Carolina, USA.Google Scholar
  46. 46.
    Pelkonen O, Nebert DW (1982) Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev 34:189–222.PubMedGoogle Scholar
  47. 47.
    Peluso M, Castegnaro M, Malaveille C, Talaska G, Vineis P, Kadlubar F, Bartsch H (1990) 32P-Postlabelling analysis of DNA adducted with urinary mutagens from smokers of black tobacco. Carcinogenesis 11:1307–1311.CrossRefPubMedGoogle Scholar
  48. 48.
    Peluso M, Castegnaro M, Malaveille C, Friesen M, Garren L, Hantefenille A, Vineis P, Kadlubar F, Bartsch H (1991) 32Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent. Carcinogenesis 12:713–717.CrossRefPubMedGoogle Scholar
  49. 49.
    Perera F, Mayer J, Jaretzki A, Hearne S, Brenner D, Young TL, Fischman HK, Grimes M, Grantham S, Tang MX, Tsai W.Y, Santella RM (1989) Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls. Cancer Res 49:4446–4451.PubMedGoogle Scholar
  50. 50.
    Philips DH, Hewer A, Grover PL (1986) Aromatic DNA adducts in human bone marrow and peripheral blood leucocytes. Carcinogenesis 7:2071–2075.CrossRefGoogle Scholar
  51. 51.
    Randerath E, Miller RH, Mittal D, Avitts TA, Dunsdorf H, Randerath K (1989) Covalent DNA damage in tissue of smokers as determined by 32P-postlabeling assay. J Natl Cancer Inst 81:341–347.CrossRefPubMedGoogle Scholar
  52. 52.
    Reddy MV, Randerath K (1986) Nuclease P1-mediated enhancement of sensitivity of 32P-postlabelling test for structurally diverse DNA adducts. Carcinogenesis 7:1543–1551.CrossRefPubMedGoogle Scholar
  53. 53.
    Reddy MV, Randerath K (1990) A comparison of DNA formation in white blood cells and internal organs of mice to benzo[a]pyrene, dibenzo[c,g] carbazole, safrole and cigarette smoke condensate. Mutat Res 241:37–48.CrossRefPubMedGoogle Scholar
  54. 54.
    Remmer H (1987) Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine. Arch Toxicol 61:89–104.CrossRefPubMedGoogle Scholar
  55. 55.
    Repace JL, Lowrey AH (1985) A quantitative estimate of non-smokers lung cancer risk from passive smoking. Environ Int 11:3–22.CrossRefGoogle Scholar
  56. 56.
    Russell MAH (1987) Estimation of smoke dosage and mortality of nonsmokers from environmental tobacco smoke. Toxicol Lett 35:9–18.CrossRefPubMedGoogle Scholar
  57. 57.
    Salomaa S, Tuominen J, Skyttä E (1988) Genotoxicity and PAC analysis of particulate and vapour phases of environmental tobacco smoke. Mutat Res 204:173–183.CrossRefPubMedGoogle Scholar
  58. 58.
    Sasson IM, Coleman DT, La Voie EJ, Hoffman D, Wynder EL (1985) Mutagens in human urine: effects of cigarette smoking and diet, Mutat Res 158:149–157.CrossRefPubMedGoogle Scholar
  59. 59.
    Savela K, Hemminki K (1991) DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32P-postlabelling assay. Carcinogenesis 12:503–508.CrossRefPubMedGoogle Scholar
  60. 60.
    Scherer G, Westphal K, Biber A, Hoepfner I, Adlkofer F (1987) Urinary mutagenicity after controlled exposure to environmental tobacco smoke (ETS). Toxicol Lett 35:135–140.CrossRefPubMedGoogle Scholar
  61. 61.
    Scherer G, Westphal K, Adlkofer F, Sorsa M (1989) Biomonitoring of exposure to potentially mutagenic substances from environmental tobacco smoke. Environ Int 15:49–56.CrossRefGoogle Scholar
  62. 62.
    Scherer G, Conze C, v Meyerinck L, Sorsa M, Adlkofer F (1990) Importance of exposure to gaseous and particulate phase components in tobacco smoke in active and passive smokers. Int Arch Occup Environ Health 62:459–466.CrossRefPubMedGoogle Scholar
  63. 63.
    Scherer G, Kratschmer A, Adlkofer F (1990) DNA adducts in monocytes after exposure to tobacco smoke (abstract). J Cancer Res Clin Oncol 116 [Suppl Part 1]:64.Google Scholar
  64. 64.
    Scherer G, Krätschmer A, Adlkofer F (1991) DNA adducts formed by urinary extracts from smokers, passive smokers and non-smokers. Poster presented at ‘Herbstkongress’ der deutschen Gesellschaft für Pharmakologie und Toxikologie, 10–14 September, 1991, Berlin, FRG.Google Scholar
  65. 65.
    Sonnenfeld G, Wilson DM (1987) The effect of smoke age and dilution on the cytotoxicity of sidestream (passive) smoke. Toxicol Lett 35:89–94.CrossRefPubMedGoogle Scholar
  66. 66.
    Sorsa M, Einistö P, Husgafvel-Pursiainen K, Jörventaus H, Kivistö H, Peltonen Y, Tuomi T, Valkonen S (1985) Passive and active exposure to cigarette smoke in a smoking experiment. J Toxicol Environ Health 16:523–534.CrossRefPubMedGoogle Scholar
  67. 67.
    Spengler JD, Dockery DW, Turner WA, Wolfson JM, Ferris BG (1981) Long term measurements of respirable sulfates and particles inside and oustide homes. Atmospheric Environment 15:23–30.CrossRefGoogle Scholar
  68. 68.
    Szadkowski D, Harke HP, Angerer J (1976) Kohlenmonoxidbelastung durch Passivrauchen in Büroräumen. Innere Medizin 3:310–313.Google Scholar
  69. 69.
    Überla K (1987) Lung cancer from passive smoking: hypothesis or convincing evidence? Int Arch Occup Environ Health 59:421–437.CrossRefPubMedGoogle Scholar
  70. 70.
    US Department of Health and Human Services (1986) The health consequences of involuntary smoking. (A report of the Surgeon General) US Government Printing Office. Washington DC.Google Scholar
  71. 71.
    Van Doorn R, Bos RP, Leijdekkers CM, Wagenaas-Zegers MAP, Theuws JLG, Henderson PT (1979) Thioether concentration and mutagenicity of urine from cigarette smokers. Int Arch Occup Environ Health 43:159–166.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • G. Scherer
    • 1
  • C. Conze
    • 1
  • A. R. Tricker
    • 1
  • F. Adlkofer
    • 1
  1. 1.Analytisch-biologisches Forschungslabor Prof. AdlkoferMünchen 2Germany

Personalised recommendations